Aggravated renal injury through HMGB1 upon TLR2/IL-1β inflammatory pathway in STZ-induced diabetic mice

Yan Yuan,Yuanxia Liu,Huijing Ye,Yuchen Feng,Zhenzhen Liu,Lingyu Pan,Hongbo Weng

DOI: https://doi.org/10.21203/rs.3.rs-1086067/v1

2021-11-30

Abstract:Abstract Diabetic kidney disease (DKD) is the major cause of end-stage renal disease and is closely associated with the inflammation. The aim of this study was to investigate the involvement of HMGB upon TLR2/IL-1β signaling pathway in diabetic renal injury. After intraperitoneal injection of STZ for wo consecutive days, mice developed DKD companying with remarkable renal injury, manifested with albuminuria and renal histological characteristics. In the kidney, the expressions of HMGB1, TLR2 and p-NF-κB were obviously increased, and the levels of TNF-α and IL-6 were significantly higher in DKD mice than that in normal mice. The infiltration of macrophages demonstrated by high stain of F4/80 and CD14 in the kidney of DKD mice. Furthermore, fibrosis related marker of Collagen IV, fibronectin and TGF-β1 showed highly expressions and accumulated in the kidney of DKD mice. In vitro , HMGB-mediated inflammatory pathway was activated in HMGB1/IL-1β-treated HK-2 cell, while C29 (a TLR2 inhibitor) could inhibited the HMGB1 expression. The result indicated that HMGB1-mediated TLR2/IL-1β signaling pathways facilitated macrophage recruitment and fibroblast proliferation, which resulting in a positive feedback to sustain a self-perpetuating cycle of renal inflammation. Therefore, HMGB1 might be a potential target in DKD therapeutic interventions.